Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of celecoxib may be an effective way to prevent
the recurrence of stage I or stage II head and neck cancer or stage I non-small cell lung
cancer.
PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works
compared to that of a placebo in preventing disease recurrence in patients with stage I or
stage II head and neck cancer or stage I non-small cell lung cancer.